CPRX will be over 4 shortly, requires lots of patience. Fundamentals are great 85% insider ownership insider CEO and Director buying.
17% biomarin BMRN ownership with great EU sales YTD 12 million 4.1 Million Q3. 4 top biotech funds on boards Orbimed & New Leaf. 3 Buy targets of over 4.00 - 5.50 by Roth and Ageis Capital, just reiterated Buy by Roth Again. FIRDAPSE is a Orphan Drug by FDA, end of year enrollment will drive price way above 4 and earning are 2nd week of November. Not to mention all price targets don't factor in CPP-115, any leak or rumor of news on CPP-115 which was developed by Dr Silverman inventor of Lyrica and Neurontin 2 Billion dollar blockbusters will propel CPRX in to uncharted territory. Both these. This drug itself is a pipeline in a Pill worth billions for multiple indication as Tourette's and infantile spasms. There has even been evidence of Firdaspe working on multiple sclerosis patients. Both these drugs will come to fruition and make million if not billions for CPRX my original PT was 16 and I still stand by it and only accumulating more at these cheap levels. Adam Fuerestein and his paid Jacbus escapade is worth nothing, 25 yrs and no FDA approval and only entering phase 2 but when you look up the company it is a guy living In a house and has no website or statement. Remember he's a paid writer and has funds shorting based on his market manipulation tactics, he's been doing this for years. The CEO is well aware of him and said there is no competition for CPRX, Patience and this is the next Acadia in a few Months! Price will consolidate and one day soar, just have Patience and remember my post!
And Today More Insider buying by David S. Tierney! Don't Be Fooled!!! FDA AEGIS ROTH AND INSIDERS ARENT ALL OUT OF THERE MINDS WATCH AND SEE THESE PRICES ARE A GIFT
Sentiment: Strong Buy
Firdapse Q3 sales $4.1M, 2013 YTD $11.8M. Only a matter of time Firadapse CPP-115, CPP-109 Completion of enrollment data! $CPRX PT 6
Remember Be Greedy When Others Are Fearful. Firdapse Enrollment Completion sooon and CPP-115 data is Around the Corner. These Lawsuits Are Baseless and nobody is suing is all #$%$ I speak to CEO on a Consistent basis! TRUST YOUR OWN DD!! DD SPEAKS VOLUMES!
Sentiment: Strong Buy
An excellent review of the positives. Thanks for summarizing. Longs should take note and not panic sell which is precisely what the manipulators wish. While AF has done damage with his misleading and motivated piece, what really matters is FDA breakthrough therapy designation and accompanying approval of Firdapse which is highly likely.